Related and Nonrelated Parties [Axis] Related Party [Member] Class of Stock [Axis] Series A Preferred Stock [Member] Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Receivables for Sale of Common Stock [Member] Retained Earnings [Member] Nonrelated Party [Member] Award Type [Axis] (15:4) Forward Stock Split [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Standby Equity Purchase Agreement [Member] Statistical Measurement [Axis] Maximum [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Antidilutive Securities [Axis] Warrant [Member] Restricted Stock Units (RSUs) [Member] Share-Based Payment Arrangement, Option [Member] Chief Executive Officer [Member] Debt Instrument [Axis] Note II Holder [Member] Title and Position [Axis] Chief Financial Officer [Member] Employment Agreements [Member] Legal Entity [Axis] YA II PN, Ltd [Member] Vesting [Axis] Share-Based Payment Arrangement, Tranche Two [Member] Twelve Convertible Promissory Notes [Member] Sale of Stock [Axis] IPO [Member] Convertible Debt I [Member] Senior Secured Note Convertible Debt II [Member] Securities Purchase Agreement [Member] Senior Secured Note [Member] Convertible Promissory Note [Member] Short-Term Debt, Type [Axis] Convertible Debt [Member] Measurement Input Type [Axis] Measurement Input, Share Price [Member] Valuation Approach and Technique [Axis] Valuation Technique, Monte Carlo Pricing Model [Member] Measurement Input, Option Volatility [Member] Measurement Input, Risk Free Interest Rate [Member] Minimum [Member] Financial Instrument [Axis] Derivative [Member] Entity One [Member] Entity Two [Member] Entity Three [Member] Underwriting Agreement [Member] Derivative Instrument [Axis] Equity Option [Member] Consultant [Member] Board of Directors [Member] Two Consultants [Member] Consultants [Member] Warrant Holder [Member] Exercise Price Range [Axis] Range One [Member] Range Two [Member] Range Three [Member] Range Four [Member] Range Five [Member] Range Six [Member] Range Seven [Member] Range Eight [Member] Service Agreements [Member] Tiberend Strategic Advisors [Member] Consulting Agreements [Member] Dominant Treasure Agreement [Member] Executive Employment Agreements [Member] License Agreements [Member] Aquanova AG [Member] Geographical [Axis] JAPAN Licensing And Royalty Agreements [Member] Debt Forgiveness and Exchange Agreement [Member] License Agreements II [Member] Murdoch Childrens Research Institute [Member] Segments [Axis] Pharmaceutical Operations [Member] Consolidation Items [Axis] Reportable Geographical Components [Member] Premium Nutritional Supplements [Member] Corporate Segment and Other Operating Segment [Member] Segment Reporting, Reconciling Item, Corporate Nonsegment [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] ICFR Auditor Attestation Flag Document Financial Statement Error Correction [Flag] Entity Listing, Par Value Per Share Auditor Firm ID Auditor Name Auditor Location Statement [Table] Statement [Line Items] Assets Current Assets: Cash Account receivable Prepaid contracts Inventory, net Other current assets Total current assets Operating lease right of use asset, net Prepaid contracts, noncurrent Other assets Total assets Liabilities and Stockholders’ Deficit Current Liabilities: Accounts payable and accrued expenses Accrued compensation Accrued interest Deferred revenue Current portion of operating lease liability Note payable, related party Convertible notes payable, fair value Other liability Total current liabilities Operating lease liability, net of current portion Total liabilities Commitments and Contingencies (Note 8) Stockholders’ Deficit: Series A preferred stock, par value $0.0001; 5,000,000 shares authorized, nil shares issued and outstanding Common stock, par value $0.0001; 500,000,000 and 125,000,000 shares authorized, respectively; 34,446,455 and 33,103,860 issued and outstanding, respectively Additional paid in capital Accumulated deficit Total stockholders’ deficit Total liabilities and stockholders’ deficit Statement of Financial Position [Abstract] Series A preferred stock, par value Series A preferred stock, shares authorized Series A preferred stock, shares issued Series A preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, share issued Common stock, share outstanding Income Statement [Abstract] Product Revenues, net Cost of goods sold Gross Profit Expenses: Research and development General and administrative Total operating expenses Operating loss Other Income (Expenses): Interest income Loss on change in fair value of derivative liability Gain on change in fair value of convertible notes Interest expense Gain on extinguishment of debt Other income Total other expenses, net Net income (loss) Net loss per common share: Basic Diluted Weighted average number of common shares outstanding: Basic Diluted Balance Balance, shares Stock-based compensation Issuance of restricted stock units for forgiveness of accrued salary Issuance of stock options for forgiveness of accrued salary Restricted stock issued for consulting agreements Restricted stock issued for consulting agreement, shares Sale of common stock Sale of common stock, shares Stock issued in connection with automatic conversion of convertible notes Stock issued in connection with automatic conversion of convertible notes, shares Stock sold in offering, net of offering costs Stock sold in offering, net of offering costs, shares Reconciling shares due to forward stock split Reconciling shares due to forward stock split, shares Net operating loss Shares issued for services rendered Shares issued for services rendered, shares Shares issued for warrant exercises Shares issued for warrant exercises, shares Shares issued in connection with warrant amendments Shares issued in connection with warrant amendments, shares Issuance of common stock for payment of interest Issuance of common stock for payment of interest, shares Commitment shares issued in connection with SEPA Commitment shares issued in connection with SEPA, shares Balance Balance, shares Defined Benefit Plan [Table] Defined Benefit Plan Disclosure [Line Items] Cash Flows from Operating Activities: Net Loss Adjustments to reconcile net loss to net cash used in operating activities: Loss on change in fair value of derivative liability Gain on change in fair value of convertible notes Amortization of debt discounts Loss (Gain) on extinguishment of debt Gain on forgiveness of accrued compensation Amortization of prepaid contracts Non-cash financing cost Interest expense paid through sale of common stock Stock-based compensation Changes in operating assets and liabilities: Increase in accounts receivable Decrease (increase) in prepaid contracts Increase in prepaid and other current assets Increase in inventory Increase in other current assets Decrease in operating lease right of use asset Increase in deferred revenue Increase in accounts payable and accrued expenses Decrease in accrued compensation Increase in accrued interest Net cash used in operating activities Cash Flows from Financing Activities: Proceeds from note payable, related parties Payment on notes payable Payment on convertible note payable Proceeds from issuance convertible note payable, net Proceeds from offering, net of offering costs Proceeds from sale of common stock Net cash provided by financing activities Net Change in Cash Beginning of period End of period Supplemental disclosure of cash flow information: Cash paid for interest Schedule of Non-Cash Investing and Financing Activities: Restricted stock issued for forgiveness of salary Stock options issued for forgiveness of salary Notes payable, related party assign to Note payable Stock issued in connection with convertible promissory notes Stock issued in connection interest payment Pay vs Performance Disclosure [Table] Executive Category [Axis] Individual [Axis] Adjustment to Compensation [Axis] Measure [Axis] Pay vs Performance Disclosure, Table Company Selected Measure Name Named Executive Officers, Footnote Peer Group Issuers, Footnote Changed Peer Group, Footnote PEO Total Compensation Amount PEO Actually Paid Compensation Amount Adjustment To PEO Compensation, Footnote Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Compensation Actually Paid Amount Adjustment to Non-PEO NEO Compensation Footnote Equity Valuation Assumption Difference, Footnote Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Company Selected Measure Total Shareholder Return Vs Peer Group Compensation Actually Paid vs. Other Measure Tabular List, Table Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Net Income (Loss) Company Selected Measure Amount Other Performance Measure, Amount Adjustment to Compensation, Amount PEO Name Name Non-GAAP Measure Description Additional 402(v) Disclosure Pension Benefits Adjustments, Footnote Equity Awards Adjustments, Footnote Erroneously Awarded Compensation Recovery [Table] Restatement Determination Date [Axis] Restatement Determination Date Aggregate Erroneous Compensation Amount Erroneous Compensation Analysis Stock Price or TSR Estimation Method Outstanding Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Not Yet Determined Name Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery, Explanation of Impracticability Name Compensation Amount Restatement does not require Recovery Awards Close in Time to MNPI Disclosures [Table] Award Timing MNPI Disclosure Award Timing Method Award Timing Predetermined Award Timing MNPI Considered Award Timing, How MNPI Considered MNPI Disclosure Timed for Compensation Value Awards Close in Time to MNPI Disclosures, Table Name Underlying Securities Exercise Price Fair Value as of Grant Date Underlying Security Market Price Change Insider Trading Arrangements [Line Items] Material Terms of Trading Arrangement Name Title Rule 10b5-1 Arrangement Adopted [Flag] Non-Rule 10b5-1 Arrangement Adopted [Flag] Adoption Date Rule 10b5-1 Arrangement Terminated [Flag] Non-Rule 10b5-1 Arrangement Terminated [Flag] Termination Date Expiration Date Arrangement Duration Aggregate Available Rule 10b5-1 Arrangement Modified [Flag] Non-Rule 10b5-1 Arrangement Modified [Flag] Insider Trading Policies and Procedures [Line Items] Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Not Adopted Cybersecurity Risk Management, Strategy, and Governance [Abstract] Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block] Cybersecurity Risk Management Processes Integrated [Flag] Cybersecurity Risk Management Processes Integrated [Text Block] Cybersecurity Risk Management Third Party Engaged [Flag] Cybersecurity Risk Third Party Oversight and Identification Processes [Flag] Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block] Cybersecurity Risk Board of Directors Oversight [Text Block] Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block] Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block] Cybersecurity Risk Role of Management [Text Block] Cybersecurity Risk Management Positions or Committees Responsible [Flag] Cybersecurity Risk Management Positions or Committees Responsible [Text Block] Cybersecurity Risk Management Expertise of Management Responsible [Text Block] Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block] Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag] Material Cybersecurity Incident [Abstract] Material Cybersecurity Incident Nature [Text Block] Material Cybersecurity Incident Scope [Text Block] Material Cybersecurity Incident Timing [Text Block] Material Cybersecurity Incident Material Impact or Reasonably Likely Material Impact [Text Block] Material Cybersecurity Incident Information Not Available or Undetermined [Text Block] Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization and Description of Business Accounting Policies [Abstract] Significant Accounting Policies Related Party Transactions [Abstract] Related Party Transactions Payables and Accruals [Abstract] Accounts Payable and Accrued Expenses Debt Disclosure [Abstract] Convertible Debt and Derivative Liability Equity [Abstract] Stockholders’ Equity (Deficit) Income Tax Disclosure [Abstract] Income Taxes Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Segment Reporting [Abstract] Segment Report Subsequent Events [Abstract] Subsequent Events Going Concern Basis of Presentation Business Segment Use of Estimates Cash Inventory Revenue Recognition Prepaid Contracts Prepaid Expenses and Other Current Assets Research and Development Income Taxes Loss Per Share of Common Stock Stock-Based Compensation Clinical Trial Expenses Fair Value of Financial Instruments and Fair Value Measurements Derivative Instruments Convertible Notes with Embedded Derivative Liabilities Leases Recent Accounting Pronouncements Schedule of Accounts Payable and Accrued Expenses Schedule of Key Assumptions in Valuation Measurement Schedule of Fair Value Derivative Liability Schedule of Derivative Liability Schedule of Stock Option Activity Schedule of Employee Stock Options Outstanding Schedule of Warrant Activity Schedule of Income Tax Provision Schedule of Deferred Tax Assets Schedule of Operating Lease Right-of-use Asset and Liability Schedule of Future Minimum Lease Liability Payments Under Non-cancelable Operating Lease Schedule of Segment Reporting Information Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Common stock shares authorized Stock split Sale of shares of common stock Stock price per share Underwriting discounts, commissions and offering expenses Sale of stock, consideration received on transaction Minimum closing bid price Market value of listed securities closed Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Net revenues Net loss Net cash flows from operating activities Accumulated deficit Cash FDIC limit Cash uninsured amount Research and development costs Number of stock options Derivative liabilities current not disclosed flag Related Party Transaction [Table] Related Party Transaction [Line Items] Loans Payable Debt Instrument, Interest Rate, Stated Percentage Interest Expense, Operating and Nonoperating Repayments of Long-Term Debt Debt Instrument, Face Amount [custom:InterestPayable-0] Share based compensation Restricted stock units Strike price Accrued compensation Shares, Issued Debt Instrument, Issued, Principal Convertible Debt Accounts payable Professional fees License fee Credit cards Total accounts payable and accrued expenses AccountsPayableAndAccruedExpensesTable [Table] Accounts payable and accrued expenses owned [custom:ConserveCashPercentage-0] Schedule of Long-Term Debt Instruments [Table] Debt Instrument [Line Items] Convertible debt instrument, measurement input Derivative liability, measurement input Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Table] Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items] Balance at December 31, 2023 Fair value change Extinguishment of derivative liability - Note II Issuance of the 2025 Notes Repayment of derivative liability Derivative liability Balance Fair value change Balance at December 31, 2025 Short-Term Debt [Table] Short-Term Debt [Line Items] Pre-paid advances via convertible promissory notes Principal amount Proceeds from issuance of debt Original issue discount percentage Interest rate Annual percentage Maturity date Debt instrument, convertible, conversion price Repayments of debt description [custom:StructuringFee-0] [custom:CommitmentShares-0] Other Commitments, Description Convertible promissory note fair value Notes payable fair value Original issue discounts Outstanding principal balance Derivative, Gain (Loss) on Derivative, Net Accrued interest expense Sale of stock, consideration received on transaction, shares Sale of stock exercise price Convertible Notes Payable [custom:OfferingPricePercentage-0] Debt Instrument, Unamortized Discount Debt Instrument, Increase, Accrued Interest Principal amount shares Common stock for net proceeds Origination costs Stock Issued During Period, Value, Conversion of Units Gain on modification Derivative liabilities Senior notes Convertible amount into shares of common stock Repayments of convertible debt Derivative liabilities not disclosed flag [custom:GainsOnExtinguishmentOfDebt] [custom:DerivativeGainLossOnDerivative] Number of options, outstanding, beginning balance Weighted average exercise price, outstanding, beginning balance Weighted average contractual term (years), outstanding Aggregate intrinsic value, outstanding, beginning balance Number of options, granted Weighted average exercise price, granted Number of options, exercised Weighted average exercise price, exercised Number of options, forfeited Weighted average contractual term (years), outstanding Weighted average exercise price, forfeited Number of options, outstanding, ending balance Weighted average exercise price, outstanding, ending balance Aggregate intrinsic value, outstanding, ending balance Number of options, exercisable Weighted average exercise price, exercisable Weighted average contractual term (years), exercisable Aggregate intrinsic value, exercisable Share-Based Payment Arrangement, Option, Exercise Price Range [Table] Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items] Exercise price Number of options, outstanding Outstanding options, weighted average remaining life Vested options, number exercisable Vested options, weighted average remaining life Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Line Items] Number of shares, outstanding, beginning balance Weighted average exercise price per share, outstanding, beginning balance Weighted average remaining life (years), outstanding Number of shares, forfeited Weighted average exercise price per share, forfeited Number of shares, exercised Weighted average exercise price per share, exercised Number of shares, forfeited Weighted average exercise price per share, forfeited Number of shares, outstanding, ending balance Weighted average exercise price per share, outstanding, ending balance Preferred stock, shares authorized Common stock, shares issued Common stock, shares outstanding Preferred stock, shares issued Preferred stock, shares outstanding Commitment shares issued Commitment shares issued value Purchase commitment Purchase commitment per share Number of shares issued for service rendered Number of restricted shares issued, shares Number of shares issued Share price Gross proceeds from offering Restricted stock fair value Compensation expense for services Net proceeds from offering Stock based compensation Unvested stock options expense Granted stock option purchase shares Stock option exercise price Grant date fair value Vested, term Stock options vest percentage Option vested Stock options issued Exercise price Vesting period description Stock option granted Fair value of grant date Vested performance description Warrant issued Warrant outstanding Warrant exercised Federal State Nondeductible expenses Change in valuation allowance Effective tax rate U.S Federal and State net operating loss Stock-based compensation Accrued salaries Orphan drug credit Derivative liability Other Total net deferred tax assets Valuation allowance Total Deferred Tax Asset Operating loss carryforward Office lease ROU Less accumulated reduction Balance of ROU, net     Office lease liability Reduction of lease liability Total 2025 2026 Total lease payments  Less: imputed interest   Total lease liabilities   Current operating lease liabilities Non-current operating lease liabilities Product Liability Contingency [Table] Product Liability Contingency [Line Items] Non-payment amount Convertible promissory note Operating lease term Base rent Operating lease yearly escalation percentage Operating lease right-of-use asset, net Operating lease liability Operating lease incremetal borrowing rate Operating leases rent expenses Agreements term Payment for services Success fee percentage Royalty payments percentage Prepaid expense Prepaid contracts expense Salary payment description [custom:LicenseFee] Accrued license fees Other Commitment Accrued and outstanding obligations Promissory note Royalty amount Number of restricted shares issued Employee Benefits and Share-Based Compensation Share based compensation Purchase of common stock Sale of Stock, Price Per Share Schedule of Segment Reporting Information, by Segment [Table] Segment Reporting Information [Line Items] Revenue Selling, general and administrative Segment net loss Other interest income (expense), net Number of reportable segments Subsequent Event [Table] Subsequent Event [Line Items] Sale of stock number of shares Proceeds from conversion debt Market value of listed securities closed Rule 10b5-1 Arrangement modified [Flag] Non-Rule 10b5-1 Arrangement modified [Flag] Gross Sales [Member] Discounts [Member] Returns [Member] Stock issued during period value issuance of restricted stock units for forgiveness of accrued salary. Stock issued during period value of issuance of stock options for forgiveness of accrued salary. Stock issued during period value stock splits. Stock issued during period value warrant exercises. Stock issued during period shares warrant exercises. Stock issued during period value commitment shares. Stock issued during period shares commitment shares. Gain loss on forgiveness of accrued compensation. Gain loss on amortization of prepaid contracts (Decrease) increase in operating lease right of use asset. Restricted stock issued for forgiveness of salary. Stock option issued for forgiveness of salary. Notes payable, related party assign to note payable. Stock issued in connection with convertible debt. Stock issued in connection interest payment. Three for One Forward Stock Split [Member] One for Two Reverse Stock Split [Member] Fifteen for Four Forward Stock Split [Member] Minimum closing bid price Prepaid contracts [Policy Text Block] Other Current Assets And Prepaid Expenses [Policy Text Block] Clinical Trial Expenses [Policy Text Block] Convertible Notes With Embedded Derivative Liabilities [Policy Text Block] Interest payable. Executive Employment Agreements [Member] Conserve cash percentage. Employment Agreements [Member] Employees [Member] Note II Holder [Member] Twelve Convertible Promissory Notes [Member] Offering price percentage. Convertible Debt I [Member] Percenatge of offering price. Offering price. Senior Secured Note Convertible Debt II [Member] Securities Purchase Agreement [Member] Debt instrument interest description. Senior Secured Note [Member] Convertible Promissory Note [Member] Convertible amount into shares of common stock. Common stock issued percentage. Gains on extinguishment of debt. Derivative gain loss on derivative. Notes Three [Member] Notes One, Two and Three [Member] Derivative fair value of issuance. Derivative fair value adjustment of date of amendment. Repayment of derivative liability. Entity One [Member] Entity Two [Member] Entity Three [Member] Underwriting Agreement [Member] Employee and Consultants [Member] Consultant [Member] Share based compensation arrangement by share based payment award options exercisable weighted average remaining contractual term. Share based compensation shares authorized under stock option plans exercise price. Range One [Member] Range Two [Member] Range Three [Member] Range Four [Member] Range Five [Member] Range Six [Member] Range Seven [Member] Range Eight [Member] Schedule of Share Based Compensation Warrant Activity [Table Text Block] Share based compensation arrangement by share based payment award non option equity instruments weighted average exercise price per share. Share based compensation arrangement by share based payment award non option equity instruments weighted average exercise price per share exercised. Share based compensation arrangement by share based payment award non option equity instruments weighted average exercise price per share forfeited. Share based compensation arrangement by share based payment award non option equity instruments weighted average remaining life. Share based compensation arrangement by share based payment award non option equity instruments weighted average exercise price per share granted. Deferred tax assets derivative liability. Tiberend Strategic Advisors [Member] Operating lease yearly escalation percentage. Operating lease incremetal borrowing rate Schedule of Operating Lease Assets and Liabilities [Table Text Block] Operating lease right-of-use asset before accumulated amortization. Operating lease, right-of-use asset, accumulated amortization. Operating lease liability gross. Reduction of operating lease liability. Rental expenses. Agreement term. Consulting Agreements [Member] Dominant Treasure Agreement [Member] Royalty percentage. License fee. License Agreements [Member] Aquanova AG [Member] Accrued license fees. Licensing And Royalty Agreements [Member] License Agreements Two [Member] Murdoch Childrens Research Institute [Member] Segment net loss. Measurement Input Probability of IPO [Member] Derivative liabilities not disclosed flag. Derivative liabilities current not disclosed flag. Gain on extinguishment of debt. Prepaid contract expenses. Cash paid for interest. Decrease (increase) in prepaid contracts. Stock sold in offering, net of offering costs. Stock sold in offering, net of offering costs, shares. Receivables for Sale of Common Stock [Member] Statement Of Income Location Balance [Axis] Issuance of common stock for payment of interest value. Issuance of common stock for payment of interest, shares Standby Equity Purchase Agreement [Member] YA II PN, Ltd [Member] Original issue discount percentage. General and Administrative Expenses [Member] Embedded conversion and settlement features. Payment premium feature. SEPA-related derivative. Straight debt component. Board of Directors [Member] Two Consultants [Member] Consultants [Member] Commitment shares. Purchase commitment per share. Warrant Holder [Member] Stock issued during period shares warrants exercised. Debt Forgiveness and Exchange Agreement [Member] Promissory note. Pharmaceutical Operations [Member] Premium Nutritional Supplements [Member] Accrued and outstanding obligations. Structuring fee Gain loss derivative instruments net pretax Gains losses of extinguishment of debt Assets, Current Assets [Default Label] Liabilities, Current Liabilities Equity, Attributable to Parent Liabilities and Equity Gross Profit Operating Expenses Operating Income (Loss) Interest Expense, Nonoperating Weighted Average Number of Shares Outstanding, Basic Weighted Average Number of Shares Outstanding, Diluted Shares, Outstanding GainLossOnForgivenessOfAccruedCompensation Increase (Decrease) in Accounts Receivable DecreaseIncreaseInPrepaidContracts Increase (Decrease) in Prepaid Expenses, Other Increase (Decrease) in Inventories Increase (Decrease) in Other Current Assets IncreaseDecreaseInOperatingLeaseRightOfUseAsset Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Repayments of Notes Payable Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation Forgone Recovery, Individual Name Outstanding Recovery, Individual Name Awards Close in Time to MNPI Disclosures, Individual Name Trading Arrangement, Individual Name Cash and Cash Equivalents, Policy [Policy Text Block] Income Tax, Policy [Policy Text Block] GainsLossesOfExtinguishmentOfDebt Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePricePerShare Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePricePerShareForfeited Effective Income Tax Rate Reconciliation, Percent Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost Deferred Tax Assets, Gross Deferred Tax Assets, Valuation Allowance Deferred Tax Assets, Net of Valuation Allowance OperatingLeaseRightOfUseAssetAccumulatedAmortization ReductionOfOperatingLeaseLiability Lessee, Operating Lease, Liability, to be Paid Lessee, Operating Lease, Liability, Undiscounted Excess Amount Assets Designated to Closed Block, Fixed Maturity, Available-for-Sale, at Fair Value